BioSpace News Archive

Acer intends to use the net proceeds from this offering to fund its research and development efforts, to seek regulatory approval for EDSIVO.

Varian today announced the publication of its 2017 annual report.

Flexpoint Sensor Systems today announces Q4 2017 topline revenue is expected to show increase and position the company for a record breaking year with revenue contributions coming from multiple key market segments.

The deal will expand Dilon’s footprint into the anesthesia and airway space.

Critical Outcome Technologies announced today that 346,428 stock options were awarded to directors under the Company’s Stock Option Plan on December 20, 2017.

The Company intends to file tender offer materials providing the holders of certain warrants the opportunity to exercise their warrants at the temporarily reduced cash exercise price.

The parts expect the closing in the first quarter 2018.

ACEA launched a comprehensive and searchable online library. “By compiling all these publications in a single location, our hope is to make this information, including protocols.

Windtree Therapeutics will host a conference call and live webcast at 8:00 AM EST on Thursday, January 4, 2018 to provide updates on the AEROSURF clinical development program and other business updates including, updated results of the AEROSURF phase 2a clinical trial in premature infants 26 - 28 weeks gestational age and other key AEROSURF development plans and business opportunities currently under consideration that could represent a catalyst for growth in 2018.

As our lead program for hearing regeneration advances on schedule, we are pleased to formally acknowledge the input from the world’s leading stem cell and regenerative medicine experts who are guiding both our hearing program and additional therapeutic opportunities for our PCA Regeneration platform.